SPATA7 Antibody

What is SPATA7 and why is it important in retinal research?

SPATA7 is a ciliary protein critical for photoreceptor function. It localizes at the connecting cilium (CC) of photoreceptor cells and is essential for proper protein trafficking between the inner segment (IS) and outer segment (OS) . Mutations in SPATA7 cause Leber congenital amaurosis (LCA3) and juvenile retinitis pigmentosa, accounting for approximately 1.7-4.6% of LCA cases in different populations . SPATA7 directly interacts with RPGRIP1, a known LCA disease protein, and facilitates the stable assembly of ciliary protein complexes that are crucial for photoreceptor function and survival .

What types of SPATA7 antibodies are available for research?

Multiple antibody formats targeting SPATA7 are available:

How do I validate SPATA7 antibody specificity in my experiments?

Proper validation requires comparing wild-type and knockout/knockdown samples. In published studies, researchers validated anti-SPATA7 antibodies by comparing immunostaining patterns between wild-type and Spata7−/− mouse retinas . When no signal was detected in the connecting cilium region of Spata7−/− retinas using the same antibody, this confirmed specificity . For western blots, validation should show bands at the expected molecular weight of approximately 64-80 kDa that disappear in knockout samples . For new antibodies, cross-validation with multiple antibodies targeting different epitopes of SPATA7 is recommended.

What are the optimal fixation and immunostaining protocols for SPATA7 detection in retinal sections?

Based on published methodologies:

• Tissue preparation:

  • Fix retinas in 4% paraformaldehyde for 1-2 hours at room temperature

  • Cryoprotect in 30% sucrose solution overnight at 4°C

  • Embed in OCT compound and section at 10-14 μm thickness

• Immunostaining protocol:

  • Permeabilize sections with 0.3% Triton X-100 in PBS for 30 minutes

  • Block with 5% normal goat serum for 1 hour

  • Incubate with primary anti-SPATA7 antibody (1:200-1:500 dilution) overnight at 4°C

  • Wash 3× with PBS

  • Incubate with appropriate secondary antibody for 1 hour at room temperature

  • Counterstain with DAPI (1:1000) for nuclear visualization

  • Mount with anti-fade mounting medium

This protocol successfully detects SPATA7 at the connecting cilium between the inner and outer segments of photoreceptors .

How should I troubleshoot weak or absent SPATA7 signal in immunostaining?

If SPATA7 immunostaining yields weak or no signal:

• Antibody sensitivity issues: Commercial anti-SPATA7 antibodies vary in sensitivity. Studies have noted that some commercial antibodies have "low sensitivity, resulting in low resolution" . Consider testing custom-generated antibodies as described in published research.

• Developmental timing: SPATA7 expression is developmentally regulated. In mouse retina, SPATA7 is first clearly detected at P4, with immunoreactivity increasing with age . By P15, the strongest immunoreactivity is observed specifically in the photoreceptor cell layer .

• Epitope masking: The connecting cilium is a structurally dense region where epitopes may be masked. Try extended antigen retrieval methods:

  • Heat-mediated antigen retrieval in citrate buffer (pH 6.0) for 10-20 minutes

  • Enzymatic retrieval with proteinase K (10 μg/ml) for 10 minutes at room temperature

• Signal amplification: Consider using tyramide signal amplification (TSA) to enhance weak signals while maintaining specificity.

How can I use SPATA7 antibodies to study protein interactions with RPGRIP1 and other ciliary proteins?

SPATA7 directly interacts with RPGRIP1 and forms part of a complex with other ciliary proteins. To study these interactions:

• Co-immunoprecipitation (co-IP):

  • Use 1-4 μg of anti-SPATA7 antibody per 1-3 mg of retinal protein lysate

  • Include appropriate controls (IgG, knockout tissue)

  • Western blot for interacting partners such as RPGRIP1, RPGR, NPHP1, NPHP4, and AHI1

• Proximity ligation assay (PLA):

  • This technique can visualize protein-protein interactions in situ with single-molecule resolution

  • Combine anti-SPATA7 with antibodies against suspected interacting partners

  • PLA signals will appear only when proteins are within 40 nm of each other

• Bimolecular fluorescence complementation (BiFC):

  • This method has successfully demonstrated SPATA7-RPGRIP1 interactions

  • Express SPATA7 and RPGRIP1 fused to complementary fragments of a fluorescent protein

  • When the proteins interact, the fragments reconstitute a functional fluorophore

How do I analyze SPATA7 localization within the connecting cilium subdomains?

The connecting cilium can be divided into proximal (PCC) and distal (DCC) regions, with SPATA7 playing a crucial role in maintaining the DCC . For precise localization:

• Super-resolution microscopy:

  • Use structured illumination microscopy (SIM) or stimulated emission depletion (STED) microscopy

  • These methods provide resolution below the diffraction limit, essential for the thin (~0.3 μm) connecting cilium

• Multi-color co-localization:

  • Co-stain with markers of specific CC subdomains:

    • Acetylated α-tubulin: marks the entire CC axoneme

    • NPHP1: normally marks the entire CC but is restricted to the PCC in Spata7 mutants

    • γ-tubulin: marks the basal body (proximal to the CC)

    • Centrin: marks the distal basal body and CC

• Quantitative analysis:

  • Measure the length of SPATA7 immunoreactivity along the connecting cilium

  • Compare with the length of other markers to determine relative positioning

  • Typical CC length in mouse photoreceptors is approximately 1.2 μm

What are the critical differences between using SPATA7 antibodies in germline versus inducible knockout models?

Recent research has revealed important distinctions when studying SPATA7 in different knockout models:

These differences highlight that SPATA7 is required not only for the initial formation but also for the maintenance of connecting cilium structures . When designing experiments, researchers should consider that "newly synthesized SPATA7 is necessary to replenish the protein pool" .

How do I distinguish between different SPATA7 isoforms in my experiments?

SPATA7 exists in multiple isoforms, with at least three identified in humans:

• Western blot analysis:

  • The molecular weight of SPATA7 is predicted to be approximately 64 kDa

  • Observed molecular weights can range from 68-80 kDa due to post-translational modifications

  • In bovine retina, RPGRIP1-interacting isoforms have been detected at approximately 150, 120, and 37 kDa

  • Use gradient gels (4-15%) for better separation of high molecular weight isoforms

• Isoform-specific detection:

  • The polyclonal antibody 12020-1-AP can recognize all three isoforms of SPATA7

  • For isoform-specific detection, design custom antibodies against unique regions

  • Note that the smallest isoform of RPGRIP1, which lacks the coiled-coil domain, does not interact with SPATA7

• Careful interpretation:

  • Post-translational modifications may cause SPATA7 to "migrate 5-8 kDa higher than expected"

  • Validate isoform identification using knockout controls or isoform-specific siRNA knockdown

How can I accurately quantify SPATA7 protein levels in retinal samples?

For reliable quantification of SPATA7:

• Western blot quantification:

  • Use gradient gels (4-15%) for optimal separation

  • Include recombinant SPATA7 protein standards for absolute quantification

  • Normalize to appropriate loading controls (β-actin for total protein; ciliary markers like acetylated α-tubulin for ciliary fractions)

  • Use fluorescent secondary antibodies for broader linear range than chemiluminescence

• ELISA-based quantification:

  • Utilize matched antibody pairs for sandwich ELISA (e.g., MP51085-2)

  • The validated detection range is 0.391-100 ng/mL for cytometric bead array applications

  • Include protein standards for calibration curves

• Mass spectrometry:

  • For absolute quantification, use isotope-labeled SPATA7 peptides as internal standards

  • Target peptides unique to SPATA7 that are reliably detected by LC-MS/MS

  • This approach can simultaneously quantify multiple proteins in the SPATA7 interactome

How should SPATA7 antibodies be used to evaluate photoreceptor degeneration mechanisms?

SPATA7 mutations lead to photoreceptor degeneration through specific mechanisms that can be evaluated using appropriate antibodies:

• Protein trafficking defects:

  • Co-stain for SPATA7 and rhodopsin to assess mislocalization

  • In Spata7−/− mice, rhodopsin accumulates in the inner segments and around nuclei of photoreceptors

  • Quantify the ratio of properly localized vs. mislocalized rhodopsin

• ER stress and apoptosis detection:

  • Co-stain SPATA7 with ER stress markers (CHOP, BiP/GRP78)

  • Use TUNEL staining to detect apoptotic cells

  • Research shows that "mislocalization of rhodopsin, leading to ER stress-mediated apoptosis, was observed in the retinal layers" of Spata7 mutants

• Temporal progression analysis:

  • Examine multiple timepoints to track disease progression

  • In Spata7−/− mice, degeneration begins between P7-P15, with progressive thinning of the outer nuclear layer (ONL)

  • By P29, ONL thickness reduces to approximately 50% of wild-type, and by 6 months, it's only 30-40%

What considerations are important when using SPATA7 antibodies in gene therapy validation studies?

For gene therapy studies targeting SPATA7-related retinal diseases:

• Expression level assessment:

  • Use quantitative western blot and immunostaining to verify that therapeutic gene expression reaches physiological levels

  • Overexpression or underexpression may fail to rescue the phenotype or cause new problems

• Localization verification:

  • Confirm that the therapeutic SPATA7 protein correctly localizes to the connecting cilium

  • Researchers have successfully used Flag-tagged SPATA7 genomic constructs that localize properly and rescue mutant phenotypes

• Functional rescue markers:

  • Monitor RPGRIP1 localization, as proper RPGRIP1 placement at the CC is a key function of SPATA7

  • Assess rhodopsin trafficking as a functional readout of CC integrity

  • Measure connecting cilium structural integrity using acetylated α-tubulin and NPHP1 staining

  • Track ONL thickness and ERG responses as physiological rescue indicators

• Timing considerations:

  • Recent research shows SPATA7 is required for both formation and maintenance of the CC

  • This suggests therapeutic intervention may be beneficial even after disease onset

How can SPATA7 antibodies be used to investigate its potential roles beyond the retina?

While SPATA7 is critical in retinal function, it's expressed in multiple tissues with poorly understood functions:

• Tissue-specific expression analysis:

  • SPATA7 is "expressed in the retina as well as in many other tissues, although it is most abundant in the testis"

  • Use tissue microarrays with validated SPATA7 antibodies to systematically assess expression patterns

  • Combine with co-expression analysis of known interacting partners

• Primary cilia in non-retinal tissues:

  • SPATA7 localizes to the primary cilium in cultured cells

  • Investigate SPATA7's role in cilia of other sensory organs, kidney tubules, or brain tissues

  • Compare protein interaction networks across different ciliated tissues

• Potential spermatogenesis functions:

  • Given its name (spermatogenesis associated protein 7) and high expression in testis, examine its role in male fertility

  • Use co-localization studies with sperm developmental markers

What new methods can enhance detection sensitivity for low abundance SPATA7 in different experimental contexts?

For improved SPATA7 detection:

• Signal amplification techniques:

  • Tyramide signal amplification can increase sensitivity up to 100-fold while maintaining specificity

  • Proximity ligation assay (PLA) can detect single molecules with high specificity

• Genetic tagging approaches:

  • BAC transgenic models expressing SPATA7::GFP have been successfully used for localization and protein interaction studies

  • CRISPR-mediated endogenous tagging preserves physiological expression levels

• Mass spectrometry with enrichment:

  • Immunoprecipitation with high-affinity antibodies followed by MS analysis has successfully identified over 160 SPATA7-interacting proteins

  • Targeted proteomics approaches like parallel reaction monitoring (PRM) can detect low-abundance proteins with high sensitivity

• Single-molecule imaging:

  • Super-resolution approaches like STORM or PALM can detect individual protein molecules

  • Single-molecule pull-down (SiMPull) combines antibody-based pull-down with single-molecule fluorescence detection

These approaches can overcome the noted limitations of some commercial antibodies that have "low sensitivity, resulting in low resolution" .